144. Antimicrobial Pharmacodynamics in Clinical Practice
Saturday, October 5, 2013: 7:00 AM-8:15 AM
Room: The Moscone Center: Esplanade Ballroom 301-310
Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe how pharmacokinetics-pharmacodynamics (PK-PD) can be used to select the best antimicrobial agent 
  • describe how PK-PD can be used to select the best dosing strategy

Target Audience: scientists, researchers, pharmacists, nurses, microbiologists, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, fellows, clinicians, academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Adult ID


7:00 AM
George Drusano, MD, FIDSA

7:35 AM
Thomas Lodise, Pharm D

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-108-L01-P


G. Drusano, Astra Zeneca: Consultant and Research Contractor, Consulting fee and Research support
Trius: Consultant, Consulting fee
Achaogen: Consultant, Consulting fee
Tetraphase: Consultant, Consulting fee
GSK: Consultant, Consulting fee
NIAID: Consultant, Consulting fee
BARDA: Consultant, Consulting fee
Cerexa: Research Contractor, Research support
Pfizer: Research Contractor, Research support

T. Lodise, None

See more of: Mini-Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.